NCT07049692View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of Hyperbaric Oxygen Combined With Endovascular Treatment in Patients With Acute Ischemic Stroke

NANot yet recruitingINTERVENTIONAL
Enrollment

424

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

December 31, 2027

Conditions
Acute Ischemic Stroke
Interventions
OTHER

Hyperbaric Oxygen Therapy

1.6 atmosphere absolute (1.6 ATA), HBO treatment administrated via mask or hood, one 60 minutes session, once daily, 10 sessions per course, inter-session intervals of fewer than 48 hours.

OTHER

High-flow oxygen therapy

1 atmosphere absolute (1 ATA), high-flow oxygen delieved at 10L/min (100%) via mask or hood, one 60 minutes session, once daily, 10 sessions per course, inter-session intervals of fewer than 48 hours.

Trial Locations (1)

Unknown

Beijing Chaoyang Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Chao Yang Hospital

OTHER

NCT07049692 - Evaluation of the Efficacy and Safety of Hyperbaric Oxygen Combined With Endovascular Treatment in Patients With Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter